this post was submitted on 02 Jan 2024
1124 points (98.2% liked)

Technology

60123 readers
3527 users here now

This is a most excellent place for technology news and articles.


Our Rules


  1. Follow the lemmy.world rules.
  2. Only tech related content.
  3. Be excellent to each another!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, to ask if your bot can be added please contact us.
  9. Check for duplicates before posting, duplicates may be removed

Approved Bots


founded 2 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
[–] WidowsFavoriteSon@lemmy.world 56 points 1 year ago (4 children)
[–] Ghostalmedia@lemmy.world 54 points 1 year ago (1 children)

I wonder if, even at this early stage of the therapy’s development, this would actually be more affordable than the alternative.

Melanoma patients are highly likely to have the cancer come back and or metastasize. Repeat treatments and hospitalizations are not cheap.

[–] overzeetop@lemmy.world 40 points 1 year ago* (last edited 1 year ago) (2 children)

Which is why the Moderna vaccine will be priced at just 95% of the cost of the repeat treatments and hospitalization plus the value of the time saved and pain and suffering avoidance by the patient. Say, an extra half a million. I mean, what price would you put on avoiding seeing your parent or child subjected to round after round of chemotherapy?

[–] FaceDeer@kbin.social -1 points 1 year ago

So if this happens exactly as you describe, the net result will be a cancer treatment that is way more reliable and causes way less suffering than the existing treatments, and is slightly cheaper to boot?

That sounds awesome!

In reality they'll likely reduce the price more than that, because the balance between the supply/demand curve will likely give them even more profit if they drop it down farther. More people will be able to afford it so it'll create a bigger market. And then in a few years competitors will start coming out with their own mRNA cancer treatments and competition will start pushing it down even more.

[–] CarrotBottom@lemmy.ml 12 points 1 year ago (3 children)

It'll be reasonably expensive, but sequencing and gene alteration is way cheaper than in needs to be.

If this can actually cure cancers, it may even be worth it.

The thing is, surely there's antibody against cancer antigens anyway, in ordinary cancer. A cancer cell expresses epitopes not on healthy cells.

Why is this better?

[–] qarbone@lemmy.world 6 points 1 year ago (1 children)

but sequencing and gene alteration is way cheaper than in[sic] needs to be.

...what? this sounds like you're advocating for price increases.

[–] CarrotBottom@lemmy.ml 13 points 1 year ago

Oops, new to Lemmy. But not new to typing, so no excuse.

I meant than "it used to be".

I blame autocorrect.

[–] theneverfox@pawb.social 3 points 11 months ago (1 children)

It's not better, ideally the body finds and eliminates cancer cells all by itself. Just like it does with viruses or infection. It happens all the time, most of the time you'd never know it happened

What this does is hardcore the "solution" into your immune cells. It tells them exactly what antibody to build, and spams that knowledge, so your immune cells are loaded up and ready to use that antibody

[–] banneryear1868@lemmy.world 2 points 11 months ago (1 children)

Yeah like we have cancerous cells in our bodies all the time, it's when our immune system isn't dealing with them that it becomes a growth or tumor.

[–] theneverfox@pawb.social 1 points 11 months ago

Exactly. And ideally not just cells growing out of control, cancerous or not. Senescent cells that no longer perform their function too - they all have bio markers that are missed.

If we could buff up elimination of cells no longer fulfilling their function, and introduce various revitalized stem cells? That's how you live to 200 baby. That's rejuvenation- it doesn't fix plaque in your arteries or structural defects, but I'm convinced it would buy you a lot of time, alongside treating the symptoms

And that gives you plenty of time for us to figure out the biomorphic field and gets you to eternal youth and body mods... That vein of science works on simple life, but mammals are complicated. It didn't take much to figure out amphibian xenobots, but we'll probably reach AI superintelligence before we figure out how to flesh sculpt with human tissue... We're a lot more delicate

I get this sounds insane to most people, but there's legit science behind my beliefs, and I can look up specific evidence on request... Just be specific with what you want further reading on, it's a complex topic

[–] arc@lemm.ee 2 points 1 year ago (1 children)

I think "reasonable" is doing a lot of heavy lifting here. Whatever price they charge it will be to maximize to Moderna's profits - i.e. they'll price it slightly lower than what insurers / national health systems would be stung for what 44% of melanoma patients needing a second round of expensive chemo would cost them but not so high that no one will cover the treatment. So I guess the price is "reasonable", in that it'll be cheaper than the alternative but it's not like Moderna will be charitable or fair about it.

It's still an amazing breakthrough though.

[–] banneryear1868@lemmy.world 1 points 11 months ago

Yeah you see this with a lot of monoclonal antibody treatments that private companies develop. They price them insanely high to recoup the insane research costs, a lot of them have reimbursement programs for patents who couldn't afford to take the drug, or who's insurance can't cover all of the drug, because they want a patient base as it adds value for their product. What happens in sane countries is you have healthcare boards negotiating prices with drug manufacturers to bring the cost down, and insurance or public plans covering what the most long-term cost effective and beneficial treatments are. Drug companies want to recoup their costs sunk in to research, and they want a patient base that can affirm the validity of the product.

Where I have a major problem is when private companies benefit from publicly funded research, or for private drug manufacturers who are merely producing single-molecule or bio-similar compounds for generic labels. IMO generic drug production should be publicly owned, as should products developed using public research grants. I would also do away with private insurance and tax schemes and use market simulation models to determine costs and efficiencies within a publicly owned framework. Small private specialty clinics I would maintain as well as research grants to private research but bringing the drug to market would be socialized and the private research institution reimbursed through that. Any essential, standardized treatments, would effectively be delivered in a fully socialized way, with smaller specialty areas being more economically "free" but in service to the broader socialized model.

[–] Welt@lazysoci.al 2 points 1 year ago

You pay tax. Tax is for roads, schools, and hospitals. Why don't you get healed when you're sick? Because you're a sucker, bro.